FDA Doubles Down on Its Pre-Catalyst Stance on Orphan Drug Exclusivity | Cooley LLP

On January 24, 2023, the Food and Drug Administration published a notice in the Federal Register to “address the uncertainty” created by the US Court of Appeals for the Eleventh...

Related Keywords

United States , ,Jacobus Pharmaceutical Co ,Catalyst Pharms Inc ,Chevron ,Drug Administration ,Us Court ,Office Of Orphan Products Development ,Federal Register ,Eleventh Circuit ,Catalyst Pharms ,Jacobus Pharmaceutical ,Administrative Procedure Act ,Orphan Drug Act ,New Drug Application ,Federal Food ,Cosmetic Act ,Retaining Access ,Restoring Exclusivity ,Orphan Products Development ,Drug Omnibus Reform Act ,Madelon Bird ,